NYSE Texas achieves a major milestone with over 100 companies dual-listed in under a year, showcasing Wall Street's shift ...

The microfluidics market offers opportunities in diagnostic healthcare, driven by the demand for precise, rapid PoCT ...

Fred Alger Management, an investment management company, released its “Alger Small Cap Focus Fund” fourth-quarter 2025 ...

The company may look to raise about ₹300-400 crore, and the promoters may liquidate some stake for the incoming investor.

Winter brings flu and pneumonia risks. Doctors share tips on testing, symptoms, and self-care to keep you healthy this season ...

Abbott projects full-year 2026 organic sales growth to be in the range of 6.5% to 7.5%. Abbott projects full-year 2026 adjusted diluted earnings per share of $5.55 to $5.80 and first-quarter 2026 ...

ADJUSTED EARNINGS: Stripping out certain one-time items, earnings are forecast to come in at $1.50 a share. That compares with adjusted earnings of $1.34 a share a year earlier. REVENUE: Quarterly ...

Imagine a simple saliva test that makes concussion screening faster and more objective than ever before. Thanks to ...

The following segment was excerpted from the Alger Mid Cap Focus Fund Q4 2025 Commentary.Class A shares of the Alger Mid Cap ...

A blood test, combined with an ultrathin material derived from graphite, could significantly advance efforts to detect ...

MaBLEM demands Malawi Govt demands accountability on botched US$30 million passport contract - The Maravi Post ...

Abbott Laboratories stock is emerging as a key way to play a potential rebound in healthcare, with analysts arguing that ...